Where you can get stem cell treatment depends entirely on what condition you’re treating. For blood cancers and certain genetic blood disorders, stem cell transplants are an established, FDA-approved procedure performed at major hospitals across the country. For joint pain, back problems, and most other conditions, the landscape is murkier: hundreds of clinics offer stem cell injections, but none of these treatments have FDA approval, and many carry real safety risks.
What the FDA Has Actually Approved
The FDA has approved stem cell products for a narrow set of conditions. The largest category is cord blood products used in bone marrow transplants for patients with blood cancers like leukemia and lymphoma, inherited blood disorders, and immune deficiencies. There are currently eight approved cord blood products, including Allocord, Clevecord, Ducord, and Hemacord, among others.
A newer category involves genetically modified stem cell therapies. Several CAR-T cell products (Kymriah, Yescarta, Breyanzi, Tecartus, Abecma, and Carvykti) treat specific blood cancers by reprogramming a patient’s own immune cells to attack cancer. Two gene therapies, Casgevy and Lyfgenia, treat sickle cell disease by modifying a patient’s blood-forming stem cells. These treatments are available at specialized cancer centers and transplant programs, not general clinics.
That’s the full list. No stem cell product is FDA-approved for arthritis, back pain, knee pain, tendonitis, disc disease, shoulder problems, or any other orthopedic condition.
Where to Get Approved Stem Cell Transplants
If you need a bone marrow or stem cell transplant for cancer or a blood disorder, you’ll want a center accredited by the Foundation for the Accreditation of Cellular Therapy (FACT). FACT accreditation means a program meets peer-defined minimum standards for quality and safety across the entire treatment process. You can search their directory of accredited organizations on the FACT website.
Major academic medical centers run the most established programs. Mayo Clinic, MD Anderson, Memorial Sloan Kettering, Fred Hutchinson Cancer Center, Dana-Farber, and dozens of university-affiliated hospitals perform these transplants routinely. Your hematologist or oncologist will typically refer you to one of these centers, and insurance (including Medicare) covers FDA-approved transplants for approved indications.
Clinical Trials for Other Conditions
If you have a condition where stem cells aren’t yet approved but show promise, clinical trials are the legitimate path. This is especially relevant for neurological diseases. Mayo Clinic’s Center for Multiple Sclerosis and Autoimmune Neurology, for example, is actively investigating stem cell approaches for aggressive MS and ALS. Their MS program uses an approach where part of the immune system is wiped out with medication, then the patient’s own bone marrow stem cells are returned to essentially reboot the immune system and stop the inflammatory damage. For ALS, safety studies are underway using stem cells injected via spinal tap, with the hope they’ll mature into nerve cells.
UC San Diego runs a stem cell program through the Sanford Consortium for Regenerative Medicine with multiple active clinical trials. Similar programs exist at Stanford, the University of Minnesota, and other research universities. You can search for active stem cell trials at ClinicalTrials.gov, filtering by your condition and location. Legitimate trials don’t charge you for the experimental treatment itself, which is one key way to distinguish them from commercial clinics.
The Unregulated Clinic Market
Hundreds of clinics across the United States market stem cell injections for joint pain, sports injuries, anti-aging, erectile dysfunction, lung disease, autism, and dozens of other conditions. The U.S. actually has the highest concentration of these clinics globally, accounting for roughly 27% of stem cell clinics marketed to medical tourists worldwide. China and India each make up about 12%, followed by Thailand at 11% and Mexico at 9%.
These clinics typically harvest stem cells from your own fat tissue or bone marrow, process them, and inject them into the affected area. Many have operated in a regulatory gray area by classifying their products as minimally manipulated human tissue rather than drugs, which historically allowed them to sidestep FDA oversight. The FDA tightened these rules in 2014 by clarifying what counts as “minimal manipulation,” but enforcement remains inconsistent.
The FDA has issued a direct consumer alert warning that many of these products are illegally marketed, have not been shown to be safe or effective, and in some cases pose significant safety risks. Reported complications include infections, tumor growth at injection sites, and blindness from eye injections.
Cost Differences Are Dramatic
FDA-approved stem cell transplants for cancer and blood disorders are covered by insurance. You’ll have copays and deductibles, but the core treatment is a standard covered procedure.
Unapproved stem cell injections at commercial clinics are almost entirely out of pocket. Most private insurers and Medicare do not cover them. Expect to pay $3,000 to $7,500 per treatment session, and many clinics recommend multiple sessions. Some international clinics charge even more for multi-day treatment packages. Related treatments like platelet-rich plasma (PRP) injections run $500 to $2,500 per session. No clinic can guarantee results for treatments that haven’t been proven effective in controlled trials, regardless of price.
Red Flags at Any Clinic
The International Society for Stem Cell Research (ISSCR), the leading professional organization in the field, has published specific warning signs to watch for. Heavy reliance on patient testimonials is a major one. Patients desperately want to believe a treatment is working, and they can genuinely convince themselves it has, even when any improvement is unrelated to the treatment. Without carefully controlled research comparing treated patients to untreated ones, there’s no way to separate real effects from placebo responses and natural fluctuations.
Other red flags include: a single clinic claiming to treat a long list of unrelated conditions with the same procedure, no independent ethics review of the treatment protocol, pressure to decide quickly, and large upfront payments. Legitimate treatment programs have regulatory approval from the FDA or an equivalent agency, or at minimum have approval from an independent review committee and institutional support from the facility where the procedure takes place.
International Clinics and Stem Cell Tourism
Stem cell tourism, where patients travel abroad for treatments unavailable or unapproved at home, is a growing global industry. Mexico, Thailand, India, Panama, and several other countries host clinics that market directly to American patients, often for neurological conditions, orthopedic problems, or autoimmune diseases.
Regulatory standards vary enormously. Japan, for instance, allows clinics to advertise regenerative medicine therapies for up to seven years after early-phase trials show basic safety, without requiring them to demonstrate ongoing treatment effectiveness. Many clinics in lower-income countries operate with minimal oversight. If something goes wrong during or after treatment abroad, follow-up care and legal recourse become far more complicated.
The safest approach for any condition is to start by searching ClinicalTrials.gov for legitimate trials, asking your specialist about emerging options, and verifying that any program you consider has proper accreditation and regulatory oversight before committing money or risking your health.